source
- Gilead and Merck’s latest trial success and flopAstraZeneca's GLP-1 pill, GSK's $10.6B cancer startup acquisition, and more biotech news from The ReadoutSTAT · 1mo ago↗ source
- STAT+: NIAID appoints new acting director after weekslong questions over leadershipThe NIH has appointed researcher John Powers III to lead its infectious disease institute on an acting basis, after weeks of being in leadership limbo.STAT · 1mo ago↗ source
- Lilly offers up to $1B for Alzheimer's drug; Bial cuts failed Parkinson's drugPlus news about Parabilis Medicines, RA Capital, Tango Therapeutics, Ideaya Biosciences, Bavarian Nordic and Cartesian Therapeutics 💸 Lilly’s $1B Alzheimer’s deal: The Indianapolis drugmaker will…Endpoints · 1mo ago